Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001005477-00-002534
Filing Date
2000-03-27
Accepted
2000-03-27 00:00:00
Documents
5
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 307103
2 COMPUTATION OF NET LOSS PER COMMON SHARE EX-11.1 1350
3 CONSENT OF INDEPENDENT ACCOUNTANTS EX-23.1 603
4 POWER OF ATTORNEY EX-24.1 149
5 FINANCIAL DATA SCHEDULE EX-27 2559
  Complete submission text file 0001005477-00-002534.txt   313648
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21589 | Film No.: 579922
SIC: 2834 Pharmaceutical Preparations